Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02554682 · ClinicalTrials.gov registry record · NA
The P4 Intervention Study to Improve Adolescent Health
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 348
- Enrollment target
NCT02554682: Completed NA study, sponsored by Children's Hospital of Philadelphia.
NCT02554682 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 348 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02554682, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 348 participants
- Enrollment target
Study Summary
The primary objective is to conduct a pilot study to determine the efficacy of evidence-based interventions delivered in primary care clinic settings on parent-teen health communication.
Primary Outcome
Parents completed the 20-item Parent-Adolescent Communication Scale (PACS) (Barnes \& Olson, 1985) which is scored such that a higher total score (sum of all items across scales) indicated better parent-adolescent communication. Teens answered the same questions, with only minor changes in wording when necessary. Scores were summed into an index that ranged from 41-96, α parent = 0.84, and 43-96, α teen = 0.87.
Interventions
- BEHAVIORAL Sexual Health
- BEHAVIORAL Alcohol Prevention
- BEHAVIORAL Teen Driving
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 348 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-04-10 |
| Phase | NA |
What the finished NCT02554682 record still lists
NCT02554682 is an interventional study that assigns participants to a tested intervention. The registered 348 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 3 interventions - of which Sexual Health is the first listed.
NCT02554682 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02554682 about?
NCT02554682 is a clinical study titled "The P4 Intervention Study to Improve Adolescent Health". The primary objective is to conduct a pilot study to determine the efficacy of evidence-based interventions delivered in primary care clinic settings on parent-teen health communication.
What is the current status of trial NCT02554682?
This trial is currently completed. It is a NA study. The enrollment target is 348 participants. The study started on 2016-01. Estimated completion is 2017-04-10.
What interventions are being tested in trial NCT02554682?
The interventions under investigation include: Sexual Health (BEHAVIORAL), Alcohol Prevention (BEHAVIORAL), Teen Driving (BEHAVIORAL).
Who is sponsoring clinical trial NCT02554682?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02554682's enrollment target sits among peer trials
348 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041479 · 348 participants · Phase 3
Biomarker-guided rTMS for Treatment Resistant Depression
- NCT04530565 · 348 participants · Phase 3
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
- NCT05428735 · 348 participants · NA
The DRAGON 2 Trial
- NCT05787379 · 348 participants · NA
Care for Veterans Post-COVID-19
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia